2 Stocks Hitting Low Notes
By
Motley Fool Staff
February 19, 2009
|
When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.
With that in mind, we'll use the aggregate intelligence of the 125,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.
Here are two such stocks:
| Company |
Today’s Intraday Price
|
Industry
|
CAPS Rating (out of 5)
|
Fools Saying Outperform
|
|
BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN)
|
$12.31
|
Biotechnology
|
|
868 of 911
|
|
National Instruments Corp (Nasdaq: NATI)
|
$18.48
|
Electronic Equipment, Instruments and Components
|
|
315 of 331
|
Source: Motley Fool CAPS, as of Feb. 19, 2009.
Top-rated biotechnology companies:
-
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA): Stock price is 41% higher than last year.
-
Cephalon, Inc. (Nasdaq: CEPH): Stock price is 22% higher than last year.
Top-rated chemicals companies:
-
Sociedad Quimica y Minera (ADR) (NYSE: SQM): Stock price is 75% higher than last year.
-
Balchem Corp (Nasdaq: BCPC): Stock price is 1% higher than last year.
Join us on CAPS to learn more about these and countless other interesting stock ideas.
Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.
Terms & Conditions
RSS Headlines
Fool UK